Skip to main content

Table 1 Demographics of patients and medical therapy at the time of primary CABG

From: Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG

Patients [#] 192
Female [#] 34 (18%)
Age [Years] 60.9 ± 7.4
Ejection fraction [%] 63.0 ± 14.5
NYHA Class 3.0 ± 1.0
Bypasses [#] 2.4 ± 1.0
Left internal thoracic artery grafts [#] 1.0 ± 0.5
Saphenous Vein Grafts [#] 1.5 ± 1.0
Additional Grafts [#] 0.4 ± 0.5
Aspirine Intake [%] 75
Beta blockers [%] 70
Statins [%] 50
ACE Inhibitors [%] 35
Calcium Channel Blockers [%] 24